531 related articles for article (PubMed ID: 30895179)
21. Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.
Oudit GY; Kassiri Z; Zhou J; Liu QC; Liu PP; Backx PH; Dawood F; Crackower MA; Scholey JW; Penninger JM
Cardiovasc Res; 2008 Jun; 78(3):505-14. PubMed ID: 18281373
[TBL] [Abstract][Full Text] [Related]
22. Loss of P53 regresses cardiac remodeling induced by pressure overload partially through inhibiting HIF1α signaling in mice.
Li J; Zeng J; Wu L; Tao L; Liao Z; Chu M; Li L
Biochem Biophys Res Commun; 2018 Jun; 501(2):394-399. PubMed ID: 29729274
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor blockade prevents the beneficial effects of β-blocker therapy on cardiac function, angiogenesis, and remodeling in heart failure.
Rengo G; Cannavo A; Liccardo D; Zincarelli C; de Lucia C; Pagano G; Komici K; Parisi V; Scala O; Agresta A; Rapacciuolo A; Perrone Filardi P; Ferrara N; Koch WJ; Trimarco B; Femminella GD; Leosco D
Circ Heart Fail; 2013 Nov; 6(6):1259-67. PubMed ID: 24029661
[TBL] [Abstract][Full Text] [Related]
24. Endothelial Mesenchymal Transition in Hypoxic Microvascular Endothelial Cells and Paracrine Induction of Cardiomyocyte Apoptosis Are Mediated via TGFβ₁/SMAD Signaling.
Sniegon I; Prieß M; Heger J; Schulz R; Euler G
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29088068
[TBL] [Abstract][Full Text] [Related]
25. MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure.
Givvimani S; Tyagi N; Sen U; Mishra PK; Qipshidze N; Munjal C; Vacek JC; Abe OA; Tyagi SC
Arch Physiol Biochem; 2010 May; 116(2):63-72. PubMed ID: 20230216
[TBL] [Abstract][Full Text] [Related]
26. Oxidative Stress and Cardiac Remodeling: An Updated Edge.
Rababa'h AM; Guillory AN; Mustafa R; Hijjawi T
Curr Cardiol Rev; 2018 Mar; 14(1):53-59. PubMed ID: 29332590
[TBL] [Abstract][Full Text] [Related]
27. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
Frangogiannis NG
Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
[TBL] [Abstract][Full Text] [Related]
28. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
[TBL] [Abstract][Full Text] [Related]
29. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
[TBL] [Abstract][Full Text] [Related]
30. Heterozygous deletion of AKT1 rescues cardiac contractility, but not hypertrophy, in a mouse model of Noonan Syndrome with Multiple Lentigines.
Roy R; Krenz M
J Mol Cell Cardiol; 2017 Nov; 112():83-90. PubMed ID: 28911943
[TBL] [Abstract][Full Text] [Related]
31. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage.
Urayama K; Dedeoglu DB; Guilini C; Frantz S; Ertl G; Messaddeq N; Nebigil CG
Cardiovasc Res; 2009 Jan; 81(1):28-37. PubMed ID: 18806277
[TBL] [Abstract][Full Text] [Related]
32. HIMF (Hypoxia-Induced Mitogenic Factor)-IL (Interleukin)-6 Signaling Mediates Cardiomyocyte-Fibroblast Crosstalk to Promote Cardiac Hypertrophy and Fibrosis.
Kumar S; Wang G; Zheng N; Cheng W; Ouyang K; Lin H; Liao Y; Liu J
Hypertension; 2019 May; 73(5):1058-1070. PubMed ID: 30827145
[TBL] [Abstract][Full Text] [Related]
33. The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response.
Higashikuni Y; Sainz J; Nakamura K; Takaoka M; Enomoto S; Iwata H; Tanaka K; Sahara M; Hirata Y; Nagai R; Sata M
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):654-61. PubMed ID: 22116099
[TBL] [Abstract][Full Text] [Related]
34. Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B-deficient mice.
Besnier M; Galaup A; Nicol L; Henry JP; Coquerel D; Gueret A; Mulder P; Brakenhielm E; Thuillez C; Germain S; Richard V; Ouvrard-Pascaud A
FASEB J; 2014 Aug; 28(8):3351-61. PubMed ID: 24760754
[TBL] [Abstract][Full Text] [Related]
35. Regulation of Cardiac Remodeling by Cardiac Na(+)/K(+)-ATPase Isoforms.
Liu L; Wu J; Kennedy DJ
Front Physiol; 2016; 7():382. PubMed ID: 27667975
[TBL] [Abstract][Full Text] [Related]
36. Deregulation of XBP1 expression contributes to myocardial vascular endothelial growth factor-A expression and angiogenesis during cardiac hypertrophy in vivo.
Duan Q; Ni L; Wang P; Chen C; Yang L; Ma B; Gong W; Cai Z; Zou MH; Wang DW
Aging Cell; 2016 Aug; 15(4):625-33. PubMed ID: 27133203
[TBL] [Abstract][Full Text] [Related]
37. Transplantation of iPSc Restores Cardiac Function by Promoting Angiogenesis and Ameliorating Cardiac Remodeling in a Post-infarcted Swine Model.
Song G; Li X; Shen Y; Qian L; Kong X; Chen M; Cao K; Zhang F
Cell Biochem Biophys; 2015 Apr; 71(3):1463-73. PubMed ID: 25388842
[TBL] [Abstract][Full Text] [Related]
38. The role of angiotensin II, endothelin-1 and transforming growth factor-beta as autocrine/paracrine mediators of stretch-induced cardiomyocyte hypertrophy.
van Wamel AJ; Ruwhof C; van der Valk-Kokshoom LE; Schrier PI; van der Laarse A
Mol Cell Biochem; 2001 Feb; 218(1-2):113-24. PubMed ID: 11330825
[TBL] [Abstract][Full Text] [Related]
39. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
[TBL] [Abstract][Full Text] [Related]
40. Heparanase Stimulation of Physiological Cardiac Hypertrophy is Suppressed Following Chronic Diabetes Resulting in Cardiac Remodeling and Dysfunction.
Lee CS; Shang R; Wang F; Khayambashi P; Wang H; Araujo G; Puri K; Vlodavsky I; Hussein B; Rodrigues B
Diabetes; 2024 May; ():. PubMed ID: 38771953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
